𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of piroxicam on interleukin production and responsiveness in patients with ankylosing spondylitis

✍ Scribed by Edward C. Keystone; A. Shore; Paul Tan; R. Klock

Publisher
Springer
Year
1984
Tongue
English
Weight
54 KB
Volume
8
Category
Article
ISSN
0360-3997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Validation exercise of the Ankylosing Sp
Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics
✍ Stone, Millicent A. ;Inman, Robert D. ;Wright, James G. ;Maetzel, Andreas πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 3 views

## Abstract ## Objectives To define what expert clinicians consider a dramatic response in ankylosing spondylitis (AS) patients treated with biologic therapies based on patient and physician assessments of global disease activity. To compare this expert clinician‐derived criteria to the Ankylosing

The influence of peripheral arthritis on
The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index
✍ Heuft-Dorenbosch, Liesbeth ;Van Tubergen, Astrid ;Spoorenberg, Anneke ;LandewΓ©, πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

## Objectives: To assess the differences in disease activity as measured by the bath ankylosing spondylitis disease activity index (basdai) between patients with and without peripheral arthritis/enthesitis. to investigate whether scores on the basdai change by omitting the 2 questions on peripheral

Evaluation and validation of the patient
Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis
✍ Maksymowych, Walter P. ;Richardson, Rhonda ;Mallon, Catherine ;van der Heijde, D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

## Abstract ## Objective The Patient Acceptable Symptom State (PASS) constitutes an absolute level of patient well‐being and represents an ambitious target for disease management. We explored contributors to PASS, validated the PASS concept, and assessed thresholds of self‐reported outcomes below